SAJAZIR
NDC 70709-013, ICATIBANT, injection, from Cycle Pharmaceuticals Ltd-Uk.
- Product NDC
- 70709-013
- Status
- Listed
- Labeler
- Cycle Pharmaceuticals Ltd-Uk
- Dosage form
- INJECTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA212446
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70709-013 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ICATIBANT ACETATE30 mg/3mL
Pharmacologic classes
Bradykinin B2 Receptor Antagonist [EPC]; Bradykinin B2 Receptor Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70709-013-01 | 70709001301 | 1 SYRINGE, GLASS in 1 CARTON (70709-013-01) / 3 mL in 1 SYRINGE, GLASS |
| 70709-013-03 | 70709001303 | 3 SYRINGE, GLASS in 1 CARTON (70709-013-03) / 3 mL in 1 SYRINGE, GLASS |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/1756aca0-21a1-4898-8d6c-9666738db45c
Use it
Look up 70709-013 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70709-013 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70709-013. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.